MOUNTAIN VIEW, Calif., March 2, 2012 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that management is scheduled to make investor presentations at investment conferences this month.
The Company presents today at the Lazard Capital Markets Annual Medical Technology Snowbird Conference where President and CEO Dominik Beck will host a series of one-on-one meetings with institutional investors throughout the day.
The Company is also scheduled to present at the ROTH Annual Growth Stock Conference during which President and CEO Dominik Beck and CFO Jim Mackaness are scheduled to present at 1:30 p.m. Pacific Time on Wednesday, March 14th. The conference is being held March 11-14th at the Ritz-Carlton in Dana Point, CA. A live audio webcast of the ROTH presentation will be available in the Investors section of the IRIDEX website at http://www.iridex.com/.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com/.
SOURCE IRIDEX Corporation
Company, Jim Mackaness, Chief Financial Officer, +1-650-940-4700; or Investor Relations, Matt Clawson, Allen & Caron, +1-949-474-4300, matt@allencaron.com
